In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

Is a new obesity drug making people lose too much weight? Plus catch up on #ASH25 and hear how the country's scientific ...

Pre-tax profits at the main Irish arm of pharmaceutical giant Johnson & Johnson declined last year by 35% to €4.47bn.

Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the ...

Chief Medical Officer Summit 360° Now Part of Questex’s Fierce Life Sciences Portfolio; 14th Annual Conference is the Largest Annual Gathering of Biotech CMOs ...

Also on Thursday, Zealand held its Capital Markets Day in London, outlining the strategy for its weight management franchise ...

Amid a challenging climate for Vancouver’s life sciences sector, Zymeworks Inc. (Nasdaq:ZYME) stands out as a success story ...

Dr. Abribat has a proven track record of developing innovative treatments for rare diseases, achieving three successful biotech/company exits He is a seasoned scientific and operational leader ...

Long a quieter, locally focused industry, Japanese pharma giants are increasingly looking to the rest of the world for deals.

Record 32,000 applications from 54 nations vie for seventh Africa's Business Heroes awards to recognise 100 start-ups over 10 ...

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today released findings from two biotech sector ...

To address this, Thermo Fisher Scientific now offers Accelerator Drug Development: a suite of integrated services combining CDMO and CRO capabilities to streamline the drug development journey, from ...